All strains were maintained on a C57BL/6 background
Medicaid GLP-1 Coverage in 2026, By the Numbers 13 state Medicaid programs cover GLP-1s for obesity, down from 16 in October 2025 (KFF) About 7.8 million of 39.5 million adult enrollees, under 20 percent, live in a covered state Medicaid GLP-1 prescriptions grew from about 1 million in 2019 to over 8 million in 2024 Gross Medicaid GLP-1 spending reached nearly 9 billion dollars in 2024, before rebates of roughly 40 percent Nearly 40 percent of adults on Medicaid have obesity, which is why the cost math keeps breaking 9 states changed their coverage status in the past 12 months, affecting about 35 percent of enrollees How Medicaid GLP-1 Coverage Works in 2026 Federal Medicaid law requires states to cover nearly all FDA-approved drugs
So, Nutrition isn't about single ingredients
But to make a conclusion, we do need to wait until data from clinical trials come out. Until then, the emerging picture is this: Though working primarily on appetite, GLP-1 drugs are potentially able to turn down the overall volume on the most intense wants
(But fair warning: No way will insurance pay for your medication.) When will less-expensive generics be available
